On 17 August he developed severe right iliac fossa pain, and the Mousseau-Barbin tube was removed at operation from the caecum, where it was found to be on the point of perforating the wall.
On 6 September the oesophagotracheal fistulae were closed transoesophageally, through an incision in the right side of the neck. It was noted that a length of about 5 cm. of the right recurrent laryngeal nerve was missing, and histology of the excised edges of the fistulae showed no sign of tumour tissue.
On both 11 and 12 November he was given cyclophosphamide 0.5 g. intravenously, the idea being to consolidate the position.
On 25 February 1963 he was readmitted, as he still had a small oesophagotracheal fistula, and this was dealt with once more through the right side of the neck. Since then he has had no symptoms of any sort, apart from hoarseness, and when last examined, on 21 March 1968, there was no sign of recurrence or metastases.
COMMENT
The original sections have been reviewed, and there is no reason to alter the original diagnosis of anaplastic carcinoma. The malignant nature of the lesion is supported by the fact that a length of the right recurrent laryngeal nerve had disappeared, and also by the presence of a mass of typical hard malignant glands in the left side of the neck. Since no other treatment was given apart from palliation by a tube, there can be no reasonable doubt that this man's apparent cure had been occasioned by cyclophosphamide.
In my experience, though cyclophosphamide commonly gives reasonable palliation in malignant disease, a cure of this sort is unique, and -can only be expected in the tiny minority of cases.
The destruction of the tumour left a gap where it had been -a fistula which was not easy to deal with. It has stimulated the speculation that if a more completely effective cytotoxic drug is developed the surgical services, far from being underemployed, will be swamped by cases requiring repair and reconstruction. 
Congenital Cytomegalovirus Infection
Treated with Idoxuridine Brit. med.J_7., 1968, 4, [162] [163] The recent demonstration that the intravenous inoculation oT idoxuridine in herpes simplex encephalitis is not as toxic as was once thought (Breedon et al., 1966; Buckley and MacCallum, 1967; Evans et al., 1967) led us to consider its use in congenital cytomegalovirus infection. The related drug floxuridine was used by Cangir et al. (1967) with marked clinical improvement in five cases of leukaemia thought to be complicated by cytomegalovirus infection. A suitable case came under the care of one of us (A. F. C.), and idoxuridine therapy was given.
CASE REPORT
The infant was born at home one week post-mature by dates, and was the second daughter of healthy parents. The pregnancy was uneventful and the delivery normal. At birth she weighed 3.6 kg. At the age of 7 weeks she was referred to the Derbyshire Children's Hospital because her general practitioner thought her head was small and she was not thriving. She had been irritable, fed poorly, and had not yet smiled. At that time her head circumference (33.6 cm.) was below the tenth percentile for her chronological age. The anterior fontanelle was patent and exhibited normal tension. There was no detectable chorioretinitis. The arms were held flexed at the elbows with the hands clenched, and the legs were extended; muscle tone was increased in all four limbs. X-ray examination of her skull showed patchy intracerebral calcification.
Antibody studies on the mother showed complement-fixing titres of 1/320 to cytomegalovirus, and 1/32 to adenovirus, haemagglutination inhibition titre of 1/20 to rubella, and dye test titre of <1/8 to toxoplasma. Titres in the patient were 1/40, <1/8, 1/4, and <1/8 respectively.
As cytomegalovirus infection was a possibility, a sample of the infant's urine and a throat swab were obtained for virus culture. Both yielded cytomegalovirus. Treatment with idoxuridine was suggested to the parents, to whom the experimental nature of this form of therapy was explained fully, and who readily agreed to the procedure.
Treatment was begun on 18 September 1967, when the infant was 14 weeks of age. Urine samples were obtained for virus culture on two days before the institution of therapy and on each day that the idoxuridine was administered. After that further specimens were obtained at less frequent intervals. Cerebrospinal fluid obtained by lumbar puncture just before treatment showed no abnormality. Cytomegalovirus was not isolated from this specimen. Because of the cytotoxic action of the drug used, a full blood count was performed on the same days that the urine samples were taken, and on several days after treatment. The haemoglobin fell from a level of 11.6 g./100 ml. before treatment to a minimum of 9.8 g./100 ml., but returned to 10.7 g./100 ml. 12 days after treatment. TREATMENT A total of 600 mg. of idoxuridine per kg. body weight was given by intravenous infusion over a period of five days, 200 mg./kg. being given on the first day and 100 mg./kg. on the subsequent four days. A sample of each batch of prepared drug was checked for sterility on the day that it was used. The fluid wvas given on Medical Memoranda MEDICAL IJoL 163 the first day of treatment by infusion into a scalp vein. However, owing to technical difficulties on the subsequent days, the right internal saphenous vein was used. This was cannulated through an incision at the ankle. On each occasion the infusion was given over a period of one and a half to two hours. On the last day of treatment the child became pyrexial, and it was apparent that the incision over the right ankle had become infected. A swab taken from this site yielded a growth of Staphylococcus aureus, coagulasepositive, and the infection was treated with oral cloxacillin in a dosage of 125 mg. six-hourly for six days. This infection coincided with a prompt response in the leucocyte count, and clearly demonstrated that the idoxuridine was-having no adverse effect on white blood cell formation. The idoxuridine for intravenous inoculation consisted of a 0.5%, (w/v) solution of 5-iodo-2'-deoxyuridine (IDU) in 5% aqueous glucose solution at pH 9, and was prepared 
CLINICAL ASSESSMENT
Before the course of treatment it had been observed that the child was very irritable and pale, and fed extremely poorly. Within one week of completion of idoxuridine therapy she was far more contented, ready to feed, and appeared well.
Her progress was reviewed in the outpatient clinic when she was aged 22 weeks. At that time she was reaching out for objects, ready to laugh, and her parents commented on the general improvement in her well-being. There was still evidence of increased tone in her limbs, but this was less marked than before the idoxuridine therapy. The head circumference, however, had increased by only 3.8 cm. and had fallen progressively below the tenth percentile. When she was seen again at the age of 10 months her limbs were still spastic, but she was feeding well and thriving. There had been little progress in her motor development, and her head circumference remained below the tenth percentile for her chronological age.
VIRUS ASSESSMENT
Human fibroblast cultures of approximately equal sensitivity to cytomegalovirus were used for the isolation and titration of the virus. Dugdale and Siddall (to be published) have shown that the isolation rate of cytomegalovirus did not vary significantly in four types of human fibroblast cultures, three of which were used in this study. The amount of virus present in urine samples was estimated by two methods: (1) By observation of cytopathic effect in fibroblast cultures after the inoculation of 0.2-ml. amounts of serial tenfold dilutions of urine. Titres were read after 12 and 26 days' incubation. (2) By a count of the number of microplaques present in fibroblast cultures 48 hours after the inoculation of undiluted urine. Results obtained by both methods are given in the Table, and results by method 2 are shown in the Chart.
As can be seen, there was a marked difference in titre before and after treatment. The inoculation of fibroblast cultures with 0.2 ml. of urine specimens obtained before and during the first three days of treatment produced the characteristic rounding of between 10' and 10' of the cells in test-tube cultures after 24 to 48 hours, while on the fourth day of treatment and thereafter cytopathic effects in the cells were less pronounced, and in some cases only identified after five to seven days of incubation, denoting a considerable drop in titre of virus in the urine. Virus was present in the saliva in all specimens, but this was not titrated as the level was much lower than in the urine, specimens taking 7 to 10 days to produce the first signs of a cytopathic effect. 
